Marina Gysin Selected Research

apramycin

4/2024	Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine blood stream infection models.
10/2022	Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
9/2021	Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland.
8/2020	Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene aac(3)-IV.
1/2020	Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina Gysin Research Topics

Disease

4	Infections 04/2024 - 08/2020
2	Bacterial Infections (Bacterial Infection) 08/2020 - 01/2020
1	Bacteremia 04/2024
1	Peritonitis 04/2024
1	Gonorrhea 02/2024
1	Bacterial Pneumonia 09/2021
1	COVID-19 09/2021
1	Superinfection 09/2021
1	Ototoxicity 01/2021

Drug/Important Bio-Agent (IBA)

6	AminoglycosidesIBA 04/2024 - 01/2020
5	apramycinIBA 04/2024 - 01/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 04/2024 - 08/2020
1	gentamicin CIBA 02/2024
1	Gentamicins (Gentamicin)FDA LinkGeneric 02/2024
1	Netilmicin (Netromycin)FDA Link 02/2024
1	etimicinIBA 02/2024
1	Amikacin (A.M.K)FDA LinkGeneric 09/2021
1	IsoenzymesIBA 01/2021
1	propylamycinIBA 01/2021

Therapy/Procedure

2	Therapeutics 09/2021 - 08/2020
1	Mechanical Ventilators (Ventilator) 09/2021